NewCardio

NewCardio Dividend

Dividend of NewCardio (NWCI) as of Nov 11, 2026.

Dividend

0.00USD

Last updated:

How much dividend does NewCardio 2026 pay?

According to the latest status from November 2026, NewCardio paid a total of 0.00 USD per share in dividends within the last 12 months. With the current NewCardio price of 0.00 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical NewCardio Dividends

Historical NewCardio Dividends
PaydateDividend

The NewCardio Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2006
0.00 USD
Jan 1, 2007
0.00 USD
Jan 1, 2008
0.00 USD
Jan 1, 2009
0.00 USD
Jan 1, 2010
0.00 USD
Jan 1, 2011 (e)
0.00 USD
Jan 1, 2012 (e)
0.00 USD
The NewCardio Dividend history
YEARDividendYoY
est0.00USD—
est0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Is the NewCardio Dividend Safe?

NewCardio has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding NewCardio's Dividend Distributions

NewCardio’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining NewCardio's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

NewCardio's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in NewCardio’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

NewCardio Stock analysis

What does NewCardio do? NewCardio Inc is a leading company in the medical technology industry that specializes in the development and marketing of innovative solutions to improve cardiovascular diagnostics and patient monitoring systems. The company's history began in 2003 when a group of experts and experienced scientists from the medical technology industry decided to develop a new technology together to monitor the electrical activity of the heart. This technology was intended to allow for more accurate diagnosis of cardiovascular diseases and thus provide better treatment options. Over the following years, several patents were filed and the technology was further developed. In 2008, NewCardio Inc was finally founded with the goal of launching the portfolio. NewCardio Inc's business model is based on the development and marketing of CardioBip systems, the company's core technology. The CardioBip system is a non-invasive, wireless, ECG-supported monitoring platform to improve cardiovascular diagnostics. The system is based on the analysis of real-time ECG data transmitted via Bluetooth to a smartphone or other mobile device. The company operates several business areas, including medical technology, clinical trials, and KinetoGen. The medical technology division focuses on the development and marketing of products that improve cardiovascular diagnostics. The CardioBip system is the core product of the medical technology division, but other products such as CardioVolt, CardioCore, and CardioKit are also available. These products offer a variety of features that improve cardiovascular diagnostics and offer numerous applications. The clinical trials division provides support for conducting clinical trials. The company offers digital, wireless ECG monitoring and efficient data analysis to ensure better clinical research. NewCardio's products enable more efficient conduct of clinical trials, saving time and costs. The KinetoGen division is a joint venture with Kineticor, a company that develops technologies for monitoring patients after surgical procedures. The joint venture specializes in the development of products that improve the prognosis and management of postoperative cardiovascular disorders. NewCardio Inc is committed to providing innovative solutions and technologies to improve cardiovascular diagnostics. NewCardio's products are unique in the market as they represent a wireless, non-invasive solution for monitoring cardiovascular diseases. Overall, NewCardio Inc is a unique company whose products and technologies improve cardiovascular diagnostics and optimize patient care. The company is focused on growth and continues to work on developing new innovative solutions to expand its portfolio. NewCardio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewCardio stock

NewCardio paid dividends every year for the past 0 years.

NewCardio is assigned to the 'Health' sector.

The dividends of NewCardio are distributed in USD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — NewCardio